The Biden administration will not reimpose COVID-19 lockdowns, even as other nations implement them amid rising caseloads. “We can curb the spread of the virus without having to in any way shut down our economy,” said COVID-19 response coordinator Jeff Zients. (CNBC Weekly)

A congressional committee has called on former FDA commissioner Stephen Hahn to appear for questioning as part of an investigation into the Trump administration’s handling of the pandemic. The committee is focusing on the government’s messaging as well as the endorsement of treatments like hydroxychloroquine. (Politico)

A federal jury has found three retail pharmacy chains, including CVS, Walgreens and Walmart, responsible for contributing to the opioid epidemic. The pharmacies gave out opioid pills recklessly in two Ohio counties, according to the verdict. (STAT)

Gene editing pioneer David Liu is exploring treatments for Alzheimer’s disease. The method his lab is developing involves inserting the APOE2 gene into DNA to see if it reduces the risk of getting Alzheimer’s. (Business Insider)

Regeneron has made a nearly $1 billion deal with Vaccibody, which will now be known as Nykode Therapeutics. The agreement includes five new vaccine programs, three in cancer and two in infectious disease. (Endpoints News)